As reviewed by Shen et al. TfR1 is overexpressed in leukemia, glioma, glioblastoma multiforme (GBM), breast, colon, liver, ovarian, prostate, and lung cancers, where it is correlated with poor clinical outcome and response to chemotherapy (48). The gene discussed is TFRC; the disease is lung carcinoma.